Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects.

作者: Regina F. Nasyrova , Dmitriy V. Ivashchenko , Mikhail V. Ivanov , Nikolay G. Neznanov

DOI: 10.3389/FPHYS.2015.00139

关键词:

摘要: Currently, schizophrenia is considered a multifactorial disease. Over the past 50 years, many investigators have role of toxic free radicals in etiology schizophrenia. This an area active research which still evolving. Here, we review recent data and current concepts on roles nitric oxide (NO) related molecules pathogenesis NO involved storage, uptake release mediators neurotransmitters, including glutamate, acetylcholine, noradrenaline, GABA, taurine glycine. In addition, diffuses across cell membranes activates its own extrasynaptic receptors. Further, peroxidation reactive oxidative stress. Investigations reveal significant disturbances levels brain structures (cerebellum, hypothalamus, hippocampus, striatum) fluids subjects with Given central nervous system development, these changes may result neurodevelopmental associated We describe here literature NOS gene polymorphisms schizophrenia, all point to consistent results. also discuss how be new target for therapy mental disorders. Currently there been 2 randomized double-blind placebo-controlled trials L-lysine as inhibitor CNS.

参考文章(224)
Hans-Gert Bernstein, Dieter Krell, Karl-Heinz Braunewell, Bruno Baumann, Eckart D. Gundelfinger, Silvia Diekmann, Peter Danos, Bernhard Bogerts, Increased number of nitric oxide synthase immunoreactive Purkinje cells and dentate nucleus neurons in schizophrenia Journal of Neurocytology. ,vol. 30, pp. 661- 670 ,(2001) , 10.1023/A:1016520932139
E.S. Underbakke, N.B. Surmeli, B.C. Smith, S.L. Wynia-Smith, M.A. Marletta, Nitric Oxide Signaling Reference Module in Chemistry, Molecular Sciences and Chemical Engineering#R##N#Comprehensive Inorganic Chemistry II (Second Edition)#R##N#From Elements to Applications. ,vol. 3, pp. 241- 262 ,(2013) , 10.1016/B978-0-08-097774-4.00320-X
Juana Gómez-Benito, Georgina Guilera, Emilio Rojo, Oscar Pino, Antonia Najas-García, Sílvia Rufián, Neurodesarrollo o neurodegeneración: Revisión sobre las teorías de la esquizofrenia Actas Espanolas De Psiquiatria. ,vol. 42, pp. 185- 195 ,(2014)
van Rossum Jm, The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Archives internationales de pharmacodynamie et de thérapie. ,vol. 160, pp. 492- 494 ,(1966)
N. P. Mitagvariia, Hiam I. Bicher, Cerebral Blood Flow Regulation ,(2012)
Bogerts B, Bielau H, Heinemann A, Keilhoff G, Krell D, Bernstein Hg, Dobrowolny H, Hypothalamic nitric oxide synthase in affective disorder: focus on the suprachiasmatic nucleus. Cellular and Molecular Biology. ,vol. 51, pp. 279- ,(2005)
Ozan Pazvantoglu, Sahabettin Selek, I. Tuncer Okay, Cem Sengul, Koray Karabekiroglu, Nesrin Dilbaz, Özcan Erel, Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile. Psychiatry and Clinical Neurosciences. ,vol. 63, pp. 693- 700 ,(2009) , 10.1111/J.1440-1819.2009.02015.X
João Paulo Maia-de-Oliveira, Clarissa Trzesniak, Irismar R. Oliveira, Matthew J. Kempton, Tatiana M. N. de Rezende, Sandro Iego, Glen B. Baker, Serdar M. Dursun, João Paulo Machado-de-Sousa, Jaime E.C. Hallak, Níveis plasmáticos/séricos do óxido nítrico em pacientes com esquizofrenia: uma revisão sistemática e metanálise Revista Brasileira de Psiquiatria. ,vol. 34, ,(2012) , 10.1016/J.RBP.2012.07.001
Kazuto Oya, Taro Kishi, Nakao Iwata, None, Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials. Human Psychopharmacology-clinical and Experimental. ,vol. 29, pp. 483- 491 ,(2014) , 10.1002/HUP.2426
Anna Dietrich-Muszalska, Bogdan Kontek, Lipid peroxidation in patients with schizophrenia. Psychiatry and Clinical Neurosciences. ,vol. 64, pp. 469- 475 ,(2010) , 10.1111/J.1440-1819.2010.02132.X